Search results for “Endocrine Tumor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 149 patents, we discovered top 42 key players by total patent application. Novartis AG, NanoPharm Ltd., AC Immune SA are dominant in this area. They take 37.58% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 37
NanoPharm Ltd.
NEWPORT, United Kingdom
Patent: 10
AC Immune SA
Vaud, Switzerland
Patent: 9
Corcept Therapeutics, Inc.
California, United States
Patent: 9
Genentech, Inc.
California, United States
Patent: 6
Ipsen Pharma SAS
France
Patent: 6
Advanced Accelerator Applications SA
France
Patent: 5
Celgene Corp.
New Jersey, United States
Patent: 2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Ipsen Bioinnovation Ltd.
United Kingdom
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Tiburio Therapeutics, Inc.
Massachusetts, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 77 patents applied in the last 5 years. We discover 31 most active companies in this area. The fast-growing NanoPharm Ltd., Corcept Therapeutics, Inc., University of Melbourne take 32.47% of patent filing during this period.
NanoPharm Ltd.
NEWPORT, United Kingdom
Patent: 11
Corcept Therapeutics, Inc.
California, United States
Patent: 9
University of Melbourne
Victoria, Australia
Patent: 5
Cornell University
New York, United States
Patent: 5
University of Antwerp
Antwerpen, Belgium
Patent: 4
Advanced Accelerator Applications SA
France
Patent: 2
SMT Bio Co., Ltd.
South Korea
Patent: 2
Curium US LLC
United States
Patent: 2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Asan Foundation
South Korea
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 77 patents in last 5 years, we discover 28 new entrants. NanoPharm Ltd., Corcept Therapeutics, Inc., University of Melbourne are the most active new entrants in this area.
NanoPharm Ltd.
NEWPORT, United Kingdom
Patent: 11
Corcept Therapeutics, Inc.
California, United States
Patent: 9
University of Melbourne
Victoria, Australia
Patent: 5
Cornell University
New York, United States
Patent: 5
University of Antwerp
Antwerpen, Belgium
Patent: 4
SMT Bio Co., Ltd.
South Korea
Patent: 2
Curium US LLC
United States
Patent: 2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Asan Foundation
South Korea
Patent: 2
Regents of the University of California
California, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 42 patents, we discovered top 11 universities and scientific research institutions by total patent application. University of British Columbia, Cornell University, University of Melbourne are dominant in this area. They take 42.86% of the total patent filing.
University of British Columbia
British Columbia, Canada
Patent: 8
Cornell University
New York, United States
Patent: 5
University of Melbourne
Victoria, Australia
Patent: 5
University of Antwerp
Antwerpen, Belgium
Patent: 4
Philipps University of Marburg
Hessen, Germany
Patent: 2
Baylor College of Medicine
Texas, United States
Patent: 2
Imperial College London
United Kingdom
Patent: 1
Chiba University
Chiba-ken, Japan
Patent: 1
Yantai University
Shandong Sheng, China
Patent: 1
Peking University Shenzhen Graduate School
China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: